Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-15-412966
Filing Date
2015-12-23
Accepted
2015-12-23 17:11:10
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B3 d44766d424b3.htm 424B3 173185
2 GRAPHIC g44766001.jpg GRAPHIC 6928
3 GRAPHIC g44766003.jpg GRAPHIC 5980
4 GRAPHIC g44766g74y22.jpg GRAPHIC 137174
  Complete submission text file 0001193125-15-412966.txt   381140
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-208330 | Film No.: 151306442
SIC: 2834 Pharmaceutical Preparations